Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-09 Option Award | 2023-06-12 8:34 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director | 29,532 | $0 | 29,532 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:15 pm | N/A 2033-06-07 | Generation Bio Co. | GBIO | Stehman-Breen Catherine Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 6:38 pm | N/A 2033-05-23 | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 24,900 | $0 | 24,900 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-06 6:23 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 7,222 | $0 | 7,222 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 8:59 pm | 2023-06-10 2032-06-09 | Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director | 39,727 | $0 | 39,727 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:05 pm | N/A 2032-06-08 | Generation Bio Co. | GBIO | Stehman-Breen Catherine Director | 19,200 | $0 | 19,200 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-06 4:09 pm | N/A 2032-06-02 | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 19,596 | $0 | 19,596 (Direct) | View |
Ownership | 2021-07-29 7:36 pm | N/A N/A | Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director | 0 | $0 | 30,000 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:09 pm | N/A 2031-06-08 | Generation Bio Co. | GBIO | Stehman-Breen Catherine Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-27 8:43 pm | N/A 2031-05-25 | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 19,596 | $0 | 19,596 (Direct) | View |
| 2020-09-21 Conversion | 2020-09-23 7:03 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 46,299 | $0 | 176,887 (Direct) | View |
| 2020-07-31 Option Award | 2020-09-23 7:03 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 25,600 | $0 | 176,887 (Direct) | View |
Ownership | 2020-09-16 8:54 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 0 | $0 | 174,121 (Direct) | View |
| 2020-06-16 Conversion | 2020-06-18 5:32 pm | N/A N/A | Generation Bio Co. | GBIO | Stehman-Breen Catherine Director | 14,004 | $0 | 47,523 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 5:25 pm | N/A 2030-06-10 | Generation Bio Co. | GBIO | Stehman-Breen Catherine Director | 52,000 | $0 | 52,000 (Direct) | View |
Ownership | 2020-06-11 8:37 pm | N/A N/A | Generation Bio Co. | GBIO | Stehman-Breen Catherine Director | 0 | $0 | 47,523 (Direct) | View |